NYSE:STJ - St Jude Medical Stock Price, Price Target & More

$80.82 +0.13 (+0.16 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$80.69

Today's Range$80.72 - $81.31

52-Week Range$48.83 - $84.00

Volume14.74 million shs

Average Volume8.54 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield1.54%

BetaN/A

About St Jude Medical (NYSE:STJ)

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Receive STJ News and Ratings via Email

Sign-up to receive the latest news and ratings for STJ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryHealth Care Equipment

SectorN/A

SymbolNYSE:STJ

CUSIP79084910

Webwww.sjm.com

Phone+1-651-7562000

Debt

Debt-to-Equity Ratio1.20%

Current Ratio1.93%

Quick Ratio1.31%

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins14.14%

Return on Equity19.40%

Return on Assets6.75%

Miscellaneous

Employees18,000

Outstanding Shares285,590,000

St Jude Medical (NYSE:STJ) Frequently Asked Questions

What is St Jude Medical's stock symbol?

St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."

How were St Jude Medical's earnings last quarter?

St Jude Medical Inc (NYSE:STJ) issued its quarterly earnings data on Wednesday, July, 20th. The medical technology company reported $1.06 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $1.06. The medical technology company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.55 billion. St Jude Medical had a return on equity of 19.40% and a net margin of 14.14%. The firm's revenue was up 10.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.07 EPS. View St Jude Medical's Earnings History.

Has St Jude Medical been receiving favorable news coverage?

Headlines about STJ stock have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. St Jude Medical earned a daily sentiment score of 0.04 on Accern's scale. They also gave media headlines about the medical technology company an impact score of 47.23 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of St Jude Medical?

Shares of STJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is St Jude Medical's stock price today?

One share of STJ stock can currently be purchased for approximately $80.82.

How can I contact St Jude Medical?

St Jude Medical's mailing address is 1 Saint Jude Medical Dr, SAINT PAUL, MN 55117-1789, United States. The medical technology company can be reached via phone at +1-651-7562000.

MarketBeat Community Rating for St Jude Medical (STJ)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		634 (Vote Outperform)
Underperform Votes:		655 (Vote Underperform)
Total Votes:		1,289

MarketBeat's community ratings are surveys of what our community members think about St Jude Medical and other stocks. Vote "Outperform" if you believe STJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STJ will underperform the S&P 500 over the long term. You may vote once every thirty days.

St Jude Medical (NYSE:STJ) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	N/A	N/A
Consensus Rating Score:	N/A	N/A	N/A	N/A
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

St Jude Medical (NYSE:STJ) Consensus Price Target History

Price Target History for St Jude Medical (NYSE:STJ)

St Jude Medical (NYSE:STJ) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
10/22/2016	Barclays	Reiterated Rating	Equal Weight	$83.00	N/A
10/11/2016	Cowen	Reiterated Rating	Buy	$85.00	N/A
9/12/2016	Jefferies Group	Reiterated Rating	Hold	$60.00	N/A
8/28/2016	Argus	Reiterated Rating	Hold		N/A
8/28/2016	Credit Suisse Group	Reiterated Rating	Neutral	$81.00	N/A
7/21/2016	Leerink Swann	Reiterated Rating	Hold	$85.00	N/A
7/20/2016	Canaccord Genuity	Set Price Target	Hold	$85.00	N/A
7/17/2016	JPMorgan Chase	Reiterated Rating	Hold		N/A
7/15/2016	Wedbush	Downgrade	Outperform -> Neutral	$70.00 -> $84.00	N/A
5/12/2016	UBS	Downgrade	Buy -> Neutral		N/A
5/10/2016	SunTrust Banks	Downgrade	Buy -> Neutral	$70.00 -> $80.00	N/A
5/2/2016	Morgan Stanley	Downgrade	Overweight -> Equal Weight	$67.00 -> $81.00	N/A
4/30/2016	Wells Fargo	Reiterated Rating	Hold		N/A
4/29/2016	William Blair	Downgrade	Outperform -> Market Perform		N/A
4/29/2016	Needham & Company LLC	Downgrade	Buy -> Hold		N/A
4/28/2016	Piper Jaffray	Downgrade	Overweight -> Neutral		N/A

(Data available from 4/26/2016 forward)

St Jude Medical (NYSE:STJ) Earnings History and Estimates Chart

Earnings by Quarter for St Jude Medical (NYSE:STJ)

St Jude Medical (NYSE:STJ) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$1.07	$1.09	$1.08
Q2 2018	2	$1.22	$1.30	$1.26
Q3 2018	2	$1.17	$1.23	$1.20

St Jude Medical (NYSE STJ) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/19/2016	Q316	$1.01	$0.99	$1.50 billion	$1.50 billion	View	Listen
7/20/2016	Q216	$1.06	$1.06	$1.55 billion	$1.56 billion	View	Listen
4/20/2016	Q116	$0.88	$0.90	$1.43 billion	$1.45 billion	View	Listen
1/27/2016	Q415	$1.01	$1.02	$1.48 billion	$1.45 billion	View	Listen
10/21/2015	Q315	$0.97	$0.97	$1.35 billion	$1.34 billion	View	Listen
7/22/2015	Q215	$1.00	$1.03	$1.39 billion	$1.41 billion	View	Listen
4/22/2015	Q115	$0.91	$0.93	$1.3173 billion	$1.3450 billion	View	N/A
1/28/2015	Q414	$1.03	$1.03	$1.44 billion	$1.44 billion	View	N/A
10/15/2014	Q314	$0.96	$0.97	$1.39 billion	$1.38 billion	View	Listen
7/16/2014	Q214	$1.00	$1.02	$1.44 billion	$1.45 billion	View	N/A
4/16/2014	Q114	$0.95	$0.96	$1.36 million	$1.36 million	View	N/A
1/22/2014	Q413	$0.97	$0.99	$1.38 billion	$1.42 billion	View	Listen
10/16/2013	Q313	$0.89	$0.90	$1.32 billion	$1.34 billion	View	Listen
7/17/2013	Q2 2013	$0.94	$0.96	$1.36 billion	$1.40 billion	View	Listen
4/17/2013	Q1 2013	$0.91	$0.92	$1.36 billion	$1.34 billion	View	Listen
1/23/2013	Q4 2012	$0.87	$0.92	$1.37 billion	$1.37 billion	View	Listen
10/17/2012		$0.81	$0.83			View	N/A
7/18/2012		$0.87	$0.86			View	N/A
4/18/2012		$0.83	$0.86			View	N/A
1/25/2012		$0.84	$0.86			View	N/A
10/19/2011		$0.76	$0.78			View	N/A
7/20/2011		$0.84	$0.85			View	N/A
4/20/2011		$0.78	$0.80			View	N/A
1/26/2011		$0.74	$0.75			View	N/A
10/20/2010	Q3 2010	$0.68	$0.72			View	N/A
7/22/2010	Q2 2010	$0.73	$0.79			View	N/A
4/21/2010	Q1 2010	$0.68	$0.75			View	N/A
1/27/2010	Q4 2009	$0.62	$0.64			View	N/A
10/21/2009	Q3 2009	$0.58	$0.59			View	N/A
7/22/2009	Q2 2009	$0.63	$0.63			View	N/A
4/22/2009	Q1 2009	$0.58	$0.58			View	N/A
1/27/2009	Q4 2008	$0.59	$0.59			View	N/A
10/15/2008	Q3 2008	$0.57	$0.57			View	N/A
7/16/2008	Q2 2008	$0.55	$0.60			View	N/A
4/16/2008	Q1 2008	$0.51	$0.54			View	N/A
1/23/2008	Q4 2007	$0.49	$0.54			View	N/A

(Earnings results data provided by Zacks Investment Research)

St Jude Medical (NYSE:STJ) Dividend Information

St Jude Medical pays an annual dividend of $1.24 per share, with a dividend yield of 1.53%. STJ's most recent quarterly dividend payment was Tuesday, January 31.

Most Recent Dividend:	1/31/2017
Annual Dividend:	$1.24
Dividend Yield:	1.53%
Dividend Growth:	0.00% (3 Year Average)
Payout Ratio:	N/A
Track Record:	7 Years of Consecutive Dividend Growth

Dividend Payments by Quarter for St Jude Medical (NYSE:STJ)

St Jude Medical (NYSE:STJ) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
12/9/2016	quarterly	$0.31	1.55%	1/11/2017	1/13/2017	1/31/2017
8/3/2016	quarterly	$0.31	1.49%	9/28/2016	9/30/2016	10/28/2016
5/4/2016	quarterly	$0.31	1.64%	6/28/2016	6/30/2016	7/29/2016
2/19/2016	quarterly	$0.31	2.3%	3/29/2016	3/31/2016	4/29/2016
12/7/2015	quarterly	$0.29	1.9%	12/29/2015	12/31/2015	1/29/2016
8/4/2015	quarterly	$0.29	1.58%	9/28/2015	9/30/2015	10/30/2015
5/6/2015	quarterly	$0.29	1.63%	6/26/2015	6/30/2015	7/31/2015
2/20/2015	quarterly	$0.29	1.69%	3/27/2015	3/31/2015	4/30/2015
10/21/2014	quarterly	$0.27	1.81%	12/29/2014	12/31/2014	1/30/2015
7/29/2014	quarterly	$0.27	1.62%	9/26/2014	9/30/2014	10/31/2014
5/1/2014	quarterly	$0.27	1.71%	6/26/2014	6/30/2014	7/31/2014
2/24/2014	quarterly	$0.27	1.6%	3/27/2014	3/31/2014	4/30/2014
12/9/2013	quarterly	$0.25	1.68%	12/27/2013	12/31/2013	1/31/2014
7/30/2013	quarterly	$0.25	1.91%	9/26/2013	9/30/2013	10/31/2013
5/1/2013	quarterly	$0.25	2.46%	6/26/2013	6/28/2013	7/31/2013
2/25/2013	quarterly	$0.25	2.45%	3/26/2013	3/29/2013	4/30/2013
12/11/2012	quarterly	$0.23	2.59%	12/27/2012	12/31/2012	1/31/2013

(Data available from 1/1/2013 forward)

St Jude Medical (NYSE STJ) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 82.73%

Insider Trading History for St Jude Medical (NYSE:STJ)

St Jude Medical (NYSE STJ) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/5/2016	Jeff Fecho	VP	Sell	10,408	$51.71	$538,197.68	5,741
12/21/2015	Donald Zurbay	CFO	Sell	3,106	$60.96	$189,341.76	19,284
12/21/2015	Jeff Dallager	VP	Sell	501	$60.94	$30,530.94	6,081
12/18/2015	John C Heinmiller	EVP	Sell	8,009	$61.16	$489,830.44	237,211
10/28/2015	Daniel J. Starks	CEO	Sell	120,000	$62.36	$7,483,200.00	6,112,363
4/28/2015	Daniel J Starks	CEO	Sell	100,000	$72.46	$7,246,000.00
4/27/2015	Mark W Murphy	VP	Sell	5,882	$72.45	$426,150.90
4/24/2015	Jason Zellers	VP	Sell	3,566	$74.13	$264,347.58
4/24/2015	Joel Becker	Insider	Sell	17,870	$73.87	$1,320,056.90
4/24/2015	John C Heinmiller	EVP	Sell	160,000	$73.69	$11,790,400.00
4/24/2015	Lisa Andrade	CMO	Sell	5,000	$73.87	$369,350.00
4/24/2015	Stuart Essig	Director	Sell	7,750	$73.85	$572,337.50
4/22/2015	I Paul Bae	VP	Sell	34,000	$73.00	$2,482,000.00
4/22/2015	Lisa Andrade	CMO	Sell	5,000	$70.55	$352,750.00
2/10/2015	Michael A Rocca	Director	Sell	3,875	$65.57	$254,083.75
2/6/2015	Michael T Rousseau	COO	Sell	7,207	$67.31	$485,103.17
2/3/2015	Denis M Gestin	Insider	Sell	148,500	$67.13	$9,968,805.00
2/3/2015	Scott Thome	VP	Sell	6,666	$67.94	$452,888.04
2/2/2015	Mark W Murphy	VP	Sell	859	$66.92	$57,484.28
2/2/2015	Richard R Devenuti	Director	Sell	7,750	$66.43	$514,832.50
12/18/2014	John C Heinmiller	EVP	Sell	6,853	$64.60	$442,703.80
10/27/2014	Jeff Fecho	VP	Sell	500	$60.55	$30,275.00
10/23/2014	Jason Zellers	VP	Sell	33,999	$60.04	$2,041,299.96
10/22/2014	Daniel J Starks	CEO	Sell	100,000	$60.04	$6,004,000.00
7/30/2014	Mark Carlson	VP	Sell	1,198	$66.40	$79,547.20
7/29/2014	Daniel J Starks	CEO	Sell	90,000	$66.25	$5,962,500.00
7/29/2014	Mark W Murphy	VP	Sell	2,000	$66.43	$132,860.00
7/28/2014	Denis M Gestin	Insider	Sell	99,000	$66.76	$6,609,240.00
7/28/2014	Rachel Ellingson	VP	Sell	2,630	$66.72	$175,473.60
7/18/2014	Scott Thome	VP	Sell	5,997	$67.06	$402,158.82
2/6/2014	Michael Rocca	Director	Sell	5,600	$60.36	$338,016.00	16,447
2/5/2014	Scott Thome	VP	Sell	7,500	$59.57	$446,775.00
2/4/2014	Michael Rousseau	COO	Sell	4,644	$59.76	$277,525.44	18,711
1/27/2014	Jeff Fecho	VP	Sell	10,408	$61.28	$637,802.24	1,837
1/27/2014	Joel Becker	Insider	Sell	14,164	$61.58	$872,219.12	3,925
1/24/2014	Mark Murphy	VP	Sell	9,480	$63.14	$598,567.20	1,614
12/18/2013	Joel Becker	Insider	Sell	37,916	$59.54	$2,257,518.64	3,925
12/18/2013	John Heinmiller	EVP	Sell	4,144	$59.49	$246,526.56	236,357
12/16/2013	Frank Callaghan	Insider	Sell	73,826	$59.28	$4,376,405.28	4,514
12/9/2013	Daniel Starks	CEO	Sell	108,000	$59.41	$6,416,280.00	6,186,116
11/5/2013	Daniel Starks	CEO	Sell	108,000	$57.33	$6,191,640.00	6,186,116
10/31/2013	Michael T Rousseau	Insider	Sell	50,000	$57.81	$2,890,500.00
10/29/2013	Kathy Chester	VP	Sell	9,375	$58.12	$544,875.00
10/29/2013	Michael T Rousseau	Insider	Sell	50,000	$57.76	$2,888,000.00
10/28/2013	Donald Zurbay	CFO	Sell	40,000	$57.31	$2,292,400.00
10/28/2013	Mark W Murphy	VP	Sell	5,024	$57.51	$288,930.24
10/25/2013	Jason Zellers	VP	Sell	14,917	$57.15	$852,506.55
10/24/2013	Joel Becker	Insider	Sell	9,613	$56.48	$542,942.24
10/23/2013	John C Heinmiller	EVP	Sell	150,000	$56.48	$8,472,000.00
10/23/2013	Kathy Chester	VP	Sell	20,000	$56.50	$1,130,000.00
10/22/2013	Angela D Craig	VP	Sell	24,402	$56.59	$1,380,909.18
10/21/2013	Frank J Callaghan	Insider	Sell	133,096	$56.26	$7,487,980.96
10/21/2013	Mark W Murphy	VP	Sell	3,930	$56.26	$221,101.80
10/18/2013	Jason Zellers	VP	Sell	10,916	$56.56	$617,408.96
10/18/2013	Michael T Rousseau	Insider	Sell	61,000	$56.65	$3,455,650.00
10/18/2013	Wendy L Yarno	Director	Sell	22,150	$56.50	$1,251,475.00
10/4/2013	Denis Gestin	Insider	Sell	137,000	$55.25	$7,569,250.00	6,257
10/4/2013	Donald Zurbay	CFO	Sell	12,000	$55.55	$666,600.00	9,731
9/11/2013	Mark Murphy	VP	Sell	4,200	$53.50	$224,700.00	642
8/9/2013	Angela Craig	VP	Sell	13,600	$54.00	$734,400.00	2,214
8/9/2013	Frank Callaghan	Insider	Sell	11,000	$54.00	$594,000.00	5,673
7/29/2013	Jason Zellers	VP	Sell	10,359	$52.22	$540,946.98
7/29/2013	Stuart Essig	Director	Sell	5,600	$52.19	$292,264.00
7/25/2013	Kathy Chester	VP	Sell	16,250	$52.00	$845,000.00
7/22/2013	Jason Zellers	VP	Sell	7,341	$51.91	$381,071.31
7/19/2013	Donald Zurbay	CFO	Sell	50,000	$51.28	$2,564,000.00
7/19/2013	Jeff Fecho	VP	Sell	13,848	$50.82	$703,755.36
7/19/2013	Joel Becker	Insider	Sell	11,700	$50.50	$590,850.00
5/2/2013	Richard R Devenuti	Director	Sell	5,270	$40.64	$214,172.80
2/5/2013	Denis M Gestin	Insider	Sell	90,000	$41.32	$3,718,800.00
2/5/2013	Thomas R Northenscold	VP	Sell	22,000	$41.40	$910,800.00
10/25/2012	John W Brown	Director	Buy	25,000	$38.65	$966,250.00

(Data available from 1/1/2013 forward)

St Jude Medical (NYSE STJ) News Headlines

Source:

Date	Headline
	Contrasting Amedica (AMDA) and St Jude Medical (STJ) www.americanbankingnews.com - February 21 at 2:11 PM
	China Kanghui (KH) & St Jude Medical (STJ) Critical Review www.americanbankingnews.com - January 25 at 10:34 AM
	Critical Survey: St Jude Medical (STJ) versus Its Peers www.americanbankingnews.com - December 15 at 11:10 AM
	Head to Head Analysis: St Jude Medical (STJ) and Its Peers www.americanbankingnews.com - December 14 at 7:50 PM
	St Jude Medical (STJ) and Its Competitors Head to Head Survey www.americanbankingnews.com - December 14 at 5:30 AM
	Head to Head Comparison: St Jude Medical (STJ) & Its Rivals www.americanbankingnews.com - December 14 at 3:30 AM
	Contrasting St Jude Medical (STJ) and The Competition www.americanbankingnews.com - December 13 at 3:28 AM
	St Jude Medical (STJ) & Its Rivals Critical Review www.americanbankingnews.com - December 11 at 5:38 AM
	Financial Review: St Jude Medical (STJ) & Its Peers www.americanbankingnews.com - December 9 at 1:20 PM
	Analyzing St Jude Medical (STJ) & The Competition www.americanbankingnews.com - December 6 at 3:08 PM
	Critical Review: St Jude Medical (STJ) versus Its Competitors www.americanbankingnews.com - December 5 at 3:30 PM
	Head to Head Survey: St Jude Medical (STJ) & Its Competitors www.americanbankingnews.com - December 1 at 5:40 AM
	St Jude Medical (STJ) and Its Competitors Head-To-Head Survey www.americanbankingnews.com - November 30 at 5:34 AM
	Head-To-Head Comparison: St Jude Medical (STJ) and Its Peers www.americanbankingnews.com - November 28 at 5:20 PM
	St Jude Medical (STJ) versus The Competition Critical Comparison www.americanbankingnews.com - November 27 at 9:32 PM
	Critical Contrast: St Jude Medical (STJ) versus Its Rivals www.americanbankingnews.com - November 26 at 1:30 PM
	Reviewing St Jude Medical (STJ) and Its Competitors www.americanbankingnews.com - November 22 at 7:47 AM
	Analyzing St Jude Medical (STJ) and Its Rivals www.americanbankingnews.com - November 21 at 5:24 PM
	Contrasting St Jude Medical (STJ) & Its Competitors www.americanbankingnews.com - November 21 at 3:16 PM
	Reviewing St Jude Medical (STJ) & The Competition www.americanbankingnews.com - November 21 at 11:20 AM
	St Jude Medical (STJ) versus Its Peers Head to Head Survey www.americanbankingnews.com - November 21 at 1:22 AM
	Reviewing St Jude Medical (STJ) & Its Competitors www.americanbankingnews.com - November 19 at 7:14 PM
	St Jude Medical (STJ) versus Its Competitors Critical Analysis www.americanbankingnews.com - November 19 at 5:06 PM
	Comparing St Jude Medical (STJ) and Its Peers www.americanbankingnews.com - November 16 at 3:36 PM
	Uroplasty (UPI) & St Jude Medical (STJ) Head to Head Contrast www.americanbankingnews.com - November 15 at 11:24 PM
	Abbott beats Street on strong medical device, generics sales www.reuters.com - October 19 at 9:22 AM
	RPRD Diagnostics Partners With St. Jude Children's Research Hospital To Offer Comprehensive Pharmacogenetics Testing www.thestreet.com - October 19 at 9:22 AM
	Abbott tops profit estimates on strong medical device sales www.reuters.com - October 18 at 9:00 AM
	Global Pain Management Drugs & Devices Industry Forecasts (2017-2021) by Market Size (Volume and Value), Sales Price, &Gross Margin www.marketwatch.com - October 14 at 8:15 AM
	Global Pain Management Drugs & Devices Industry Forecast to 2021 with Sales, Sales Price and Gross Margin Analysis www.marketwatch.com - October 12 at 8:40 PM
	The Melting Pot Announces 14th Year of Partnership with St. Jude Children's Research Hospital Thanks and Giving® Campaign www.prnewswire.com - October 11 at 8:09 AM
	Head to Head Comparison: St Jude Medical (STJ) vs. Trivascular Technologies (TRIV) www.americanbankingnews.com - October 7 at 12:18 AM
	Mairs and Power Finds Value and Growth Close to Home finance.yahoo.com - October 6 at 10:46 AM
	DiCello Levitt & Casey and Tousley Brain Stephens File Class Action Lawsuit Over Recalled Implantable Cardiac Defibrillators www.businesswire.com - September 20 at 9:32 AM
	Head to Head Review: RTI Surgical (RTIX) & St Jude Medical (STJ) www.americanbankingnews.com - September 10 at 4:08 PM
	UPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakers www.businessinsider.com - August 31 at 10:35 AM
	St. Jude unveils powerful resource to advance treatment of pediatric solid tumors www.bizjournals.com - August 31 at 10:34 AM
	Abbott issues second round of updates on St. Jude pacers seekingalpha.com - August 30 at 9:41 AM
	Stryker Corporation (SYK) and St Jude Medical (STJ) Financial Review www.americanbankingnews.com - August 28 at 2:24 PM
	2017 Health Care Heroes Lifetime Achievement: Dr. Larry Kun with St. Jude www.bizjournals.com - August 18 at 7:32 AM
	BRIEF-IMF Bentham says Canadian unit proposes to fund class action against St. Jude Medical, Inc www.reuters.com - August 14 at 6:01 AM
	St Jude Medical (STJ) vs. Uroplasty (UPI) Head to Head Comparison www.americanbankingnews.com - August 9 at 12:24 PM
	Analyzing St Jude Medical (STJ) and Endologix (ELGX) www.americanbankingnews.com - August 2 at 12:16 AM
	St. Jude Children's Research Hospital®, ALSAC Announce Chairs of Boards of Directors and Governors www.bizjournals.com - July 25 at 7:05 AM
	Abbott Labs sales increase as St. Jude devices rebound www.bizjournals.com - July 22 at 9:12 AM
	St. Jude-led researchers identify flu-risk genetic marker www.bizjournals.com - July 18 at 8:34 AM
	Toys"R"Us® Helps Raise Nearly $3 Million For St. Jude Children's Research Hospital® www.prnewswire.com - July 13 at 9:57 AM
	Healthcare Uncertainty No Match For Abbott CFO www.forbes.com - July 11 at 3:51 PM
	RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer feeds.benzinga.com - July 10 at 8:49 AM
	St. Jude Medical fortune.com - June 7 at 10:25 AM